Unlocking the Brain’s Reward Circuitry: How Next-Generation Oral GLP-1 Medications Are Rewriting the Science of Appetite and Craving
Executive Overview The landscape of metabolic medicine is undergoing a profound transformation. For years, the conversation surrounding blockbuster weight-loss and diabetes medications—such as semaglutide (popularized under brand names like Ozempic…